Women older than 65 years who underwent catch-up testing for cervical cancer were more likely to be diagnosed with the disease than were those who did not, a new study found.
/PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration.
Becton Dickinson (BDX) Announces FDA Approval of BD Onclarity HPV Assay streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
A bill that will, if enacted, appropriate $500,000 from the general fund to the board of regents of the University of New Mexico to support the operational infrastructure for the state’s human papillomavirus pap registry passed the House Health and Human Services Committee by 6 to 2 on Friday. The one-page bill, HB 136, sponsored […]